SLC45A2 anticorps (C-Term)
Aperçu rapide pour SLC45A2 anticorps (C-Term) (ABIN635265)
Antigène
Voir toutes SLC45A2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- SLC45 A2 antibody was raised against the C terminal of SLC45 2
-
Purification
- Affinity purified
-
Immunogène
- SLC45 A2 antibody was raised using the C terminal of SLC45 2 corresponding to a region with amino acids IGWTAFLSNMLFFTDFMGQIVYRGDPYSAHNSTEFLIYERGVEVGCWGFC
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SLC45A2 Blocking Peptide, (ABIN939366), is also available for use as a blocking control in assays to test for specificity of this SLC45A2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SLC40 2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SLC45A2 (Solute Carrier Family 45, Member 2 (SLC45A2))
-
Autre désignation
- SLC45A2
-
Sujet
- SLC45A2 is a melanocyte differentiation antigen that is expressed in a high percentage of melanoma cell lines. A similar sequence gene in medaka, 'B,' encodes a transporter that mediates melanin synthesis. Mutations in this gene are a cause of oculocutaneous albinism type 4.
-
Poids moléculaire
- 51 kDa (MW of target protein)
Antigène
-